bupivacaine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helm Ii, S | 1 |
| Harmon, PC | 1 |
| Noe, C | 1 |
| Calodney, AK | 1 |
| Abd-Elsayed, A | 1 |
| Knezevic, NN | 1 |
| Racz, GB | 1 |
1 other study available for bupivacaine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Transforaminal Epidural Steroid Injections: A Systematic Review and Meta-Analysis of Efficacy and Safety.
Topics: Bupivacaine; COVID-19; Dexmedetomidine; Humans; Injections, Epidural; Patient Protection and Afforda | 2021 |